<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39432143</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1573-4978</ISSN><JournalIssue CitedMedium="Internet"><Volume>51</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>21</Day></PubDate></JournalIssue><Title>Molecular biology reports</Title><ISOAbbreviation>Mol Biol Rep</ISOAbbreviation></Journal><ArticleTitle>Potential hypothesis for the increased risk of Parkinson´s disease following COVID-19.</ArticleTitle><Pagination><StartPage>1085</StartPage><MedlinePgn>1085</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11033-024-10021-w</ELocationID><Abstract><AbstractText>Patients with severe COVID-19 may be more likely to develop PD as a result of shared biological pathways including a great expansion of MDSCs and an imbalance in Th17/Tregs ratio. We think that these shared pathogenic features may mechanistically explain the COVID-19 - PD axis. Thus, we assume that patients who recovered from critical COVID-19 should be selected based upon a potential higher risk of developing PD. Further studies are needed to better define the possible relationship between COVID-19 and neuroinflammation and identify whether some people are more likely to develop PD after contracting COVID-19 than others with special emphasis to ascertain possible vulnerable genetic backgrounds or epigenetic factors acting on brain which may promote PD during SARS COV-2 infection. Finally, we think that regular physical activity should be performed and encouraged in patients with PD.</AbstractText><CopyrightInformation>© 2024. The Author(s), under exclusive licence to Springer Nature B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mormile</LastName><ForeName>Raffaella</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Pediatrics and Neonatology, Moscati Hospital, Via A. Gramsci, Aversa, 81031, Italy. raffaellamormile@alice.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mormile</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Picone</LastName><ForeName>Carmine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Radiology, Istituto Nazionale Tumori IRCCS Fondazione Pascale-IRCCS di Napoli, Napoli, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine and Health Science, Vincenzo Tiberio University of Molise, Campobasso, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Mol Biol Rep</MedlineTA><NlmUniqueID>0403234</NlmUniqueID><ISSNLinking>0301-4851</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">MDSCs</Keyword><Keyword MajorTopicYN="N">Parkinson’s disease</Keyword><Keyword MajorTopicYN="N">Th17 cells</Keyword><Keyword MajorTopicYN="N">Tregs</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>22</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>12</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>11</Hour><Minute>18</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39432143</ArticleId><ArticleId IdType="doi">10.1007/s11033-024-10021-w</ArticleId><ArticleId IdType="pii">10.1007/s11033-024-10021-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bouali-Benazzouz R, Benazzouz A (2021) Covid-19 infection and parkinsonism: is there a link? Mov Disord 36(8):1737–1743. https://doi.org/10.1002/mds.28680</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.28680</ArticleId><ArticleId IdType="pubmed">34080714</ArticleId><ArticleId IdType="pmc">8242862</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabaan AA, Smajlović S, Tombuloglu H, Ćordić S et al (2023) SARS-CoV-2 infection and multi-organ system damage: a review. Biomol Biomed 23(1):37–52</Citation><ArticleIdList><ArticleId IdType="pubmed">36124445</ArticleId><ArticleId IdType="pmc">9901898</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmati M, Yon DK, Lee SW, Udeh R et al (2023) New-onset type 1 diabetes in children and adolescents as postacute sequelae of SARS-CoV-2 infection: A systematic review and meta-analysis of cohort studies. J Med Virol 95(6): e28833</Citation></Reference><Reference><Citation>Rahmati M, Koyanagi A, Banitalebi E, Yon DK, Lee SW, Il Shin J, Smith L (2023) The effect of SARS-CoV-2 infection on cardiac function in post-COVID-19 survivors: A systematic review and meta-analysis. J Med Virol 95(1):e28325</Citation></Reference><Reference><Citation>Peron JPS (2023) Direct and indirect impact of SARS-CoV-2 on the brain. Hum Genet 142:1317–1326. https://doi.org/10.1007/s00439-023-02549-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-023-02549-x</ArticleId><ArticleId IdType="pubmed">37004544</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandeep SR, Mondal AC (2023) Does COVID-19 Trigger the Risk for the Development of Parkinson’s Disease? Therapeutic Potential of Vitamin C. Mol Neurobiol 14. https://doi.org/10.1007/s12035-023-03756-3</Citation></Reference><Reference><Citation>Rahmati M, Yon DK, Lee SW, Soysal P et al (2023) New-onset neurodegenerative diseases as long-term sequelae of SARS-CoV-2 infection: a systematic review and meta-analysis. J Med Virol 95(7):e28909</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28909</ArticleId><ArticleId IdType="pubmed">37394783</ArticleId></ArticleIdList></Reference><Reference><Citation>Afraie M, Moradi G, Mohammadzedeh P, Azami M, Riyahifar S, Moradi Y (2023) COVID-19 and Parkinson’s disease: a systematic review and meta-analysis. Acta Neurol Belg 123(4):1209–1223</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13760-022-02141-6</ArticleId><ArticleId IdType="pubmed">36385247</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson ME, Stecher B, Labrie V, Brundin L, Brundin P (2019) Triggers, facilitators, and aggravators: redefining Parkinson’s disease pathogenesis. Trends Neurosci 42:4–13</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2018.09.007</ArticleId><ArticleId IdType="pubmed">30342839</ArticleId></ArticleIdList></Reference><Reference><Citation>Faa G, Marcialis MA, Ravarino A, Piras M, Pintus MC, Fanos V (2014) Fetal programming of the human brain: is there a link with insurgence of neurodegenerative disorders in adulthood? Curr Med Chem 21(33):3854–3876</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867321666140601163658</ArticleId><ArticleId IdType="pubmed">24934353</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhury A, Chakraborty I, Subhra Banerjee T3, Dhilleswara Rao Vana D (2018) Effect and disease indicative role of inflammation in Neurodegenerative Pathology: a mechanistic crosstalk of Promise and Dilemma- Neuropsychiatry 8(1):384–394</Citation></Reference><Reference><Citation>Liu T, Wu H, Sun L, Wei J (2024) Role of inflammation in the development of COVID-19 to Parkinson’s Disease. J Inflamm Res 17:3259–3282</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S460161</ArticleId><ArticleId IdType="pubmed">38800597</ArticleId><ArticleId IdType="pmc">11127656</ArticleId></ArticleIdList></Reference><Reference><Citation>Adalid-Peralta L, Alvarez-Luquin D, Arce-Sillas A, Leyva-Hernadez J et al (2018) Dopaminergic agonist pramipexole enhances regulatory T cell response after one-year treatment in Parkinson disease patients. Abstract 13 th World Conference on Neurology and Neuromuscular Disorders – J neur Neurophysiol 19:62</Citation></Reference><Reference><Citation>Chen S, Liu Y, Niu Y, Xu Y et al (2017) Increased abundance of myeloid-derived suppressor cells and Th17 cells in peripheral blood of newly-diagnosed Parkinson’s disease patients. Neurosci Lett 648:21–25</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2017.03.045</ArticleId><ArticleId IdType="pubmed">28359932</ArticleId></ArticleIdList></Reference><Reference><Citation>Morganstein T, Haidar Z, Trivlidis J, Azuelos I, Huang MJ, Eidelman DH, Baglole CJ (2021) Involvement of the ACE2/Ang-(1–7)/MasR Axis in Pulmonary Fibrosis: implications for COVID-19. Int J Mol Sci 22(23):12955</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222312955</ArticleId><ArticleId IdType="pubmed">34884756</ArticleId><ArticleId IdType="pmc">8657555</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J, Lütgehetmann M, Hagel C, Sperhake JP et al (2020) Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol 19(11):919–929. https://doi.org/10.1016/S1474-4422(20)30308-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30308-2</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId><ArticleId IdType="pmc">7535629</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Liu Z, Cao BB, Qiu YH, Peng YP (2020) Treg Cells Attenuate Neuroinflammation and protect neurons in a mouse model of Parkinson’s Disease. J Neuroimmune Pharmacol 15(2):224–237</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-019-09888-5</ArticleId><ArticleId IdType="pubmed">31802419</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen XZ, Okwan-Duodu D, Blackwell WL, Ong FS et al (2014) Myeloid expression of angiotensin-converting enzyme facilitates myeloid maturation and inhibits the development of myeloid-derived suppressor cells. Lab Invest 94(5):536–544</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/labinvest.2014.41</ArticleId><ArticleId IdType="pubmed">24614194</ArticleId><ArticleId IdType="pmc">4221240</ArticleId></ArticleIdList></Reference><Reference><Citation>Ip CW, Wischhusen J (2023) Versatile guardians: regenerative regulatory T cells in Parkinson’s disease rodent models. Signal Transduct Target Ther 8(1):430</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-023-01681-4</ArticleId><ArticleId IdType="pubmed">37981647</ArticleId><ArticleId IdType="pmc">10658175</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhalsing KS, Abbas MM, Tan LC (2018) Role of physical activity in Parkinson’s disease. Ann Indian Acad Neurol 21:242–249</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/aian.AIAN_169_18</ArticleId><ArticleId IdType="pubmed">30532351</ArticleId><ArticleId IdType="pmc">6238554</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsukita K, Sakamaki-Tsukita H, Takahashi R (2022) Long-term effect of regular physical activity and Exercise habits in patients with early Parkinson Disease. Neurology 98(8):e859–e871</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000013218</ArticleId><ArticleId IdType="pubmed">35022304</ArticleId><ArticleId IdType="pmc">8883509</ArticleId></ArticleIdList></Reference><Reference><Citation>Grassi G, Notari S, Gili S, Bordoni V et al (2022) Myeloid-derived suppressor cells in COVID-19: the Paradox of Good. Front Immunol 13:842949</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.842949</ArticleId><ArticleId IdType="pubmed">35572540</ArticleId><ArticleId IdType="pmc">9092297</ArticleId></ArticleIdList></Reference><Reference><Citation>Len JS, Koh CWT, Chan KR (2023) The functional roles of MDSCs in severe COVID-19 pathogenesis. Viruses 16(1):27</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v16010027</ArticleId><ArticleId IdType="pubmed">38257728</ArticleId><ArticleId IdType="pmc">10821470</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamberi L, Belloni A, Pugnaloni A, Rippo MR et al (2024) The influence of myeloid-derived suppressor cell expansion in Neuroinflammation and neurodegenerative diseases. Cells 13(7):643</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells13070643</ArticleId><ArticleId IdType="pubmed">38607083</ArticleId><ArticleId IdType="pmc">11011419</ArticleId></ArticleIdList></Reference><Reference><Citation>Martonik D, Parfieniuk-Kowerda A, Rogalska M, Flisiak R (2021) The role of Th17 response in COVID-19. Cells 10(6):1550. https://doi.org/10.3390/cells10061550</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10061550</ArticleId><ArticleId IdType="pubmed">34205262</ArticleId><ArticleId IdType="pmc">8235311</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhawan M, Rabaan AA, Alwarthan S, Alhajri M et al (2023) Regulatory T cells (Tregs) and COVID-19: unveiling the mechanisms, and therapeutic potentialities with a Special Focus on Long COVID. Vaccines (Basel) 11(3):699</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11030699</ArticleId><ArticleId IdType="pubmed">36992283</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Wang Z, Cao W, Wu Q, Yuan Y, Zhang X (2021) Regulatory T cells in COVID-19. Aging Dis 12(7):1545–1553</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2021.0709</ArticleId><ArticleId IdType="pubmed">34631206</ArticleId><ArticleId IdType="pmc">8460308</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z, Jiang X, Dai X, Li B (2022) The dynamic role of FOXP3<sup>+</sup> Tregs and their potential therapeutic applications during SARS-CoV-2 infection. Front Immunol 13:916411</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.916411</ArticleId><ArticleId IdType="pubmed">35874688</ArticleId><ArticleId IdType="pmc">9305488</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmati M, Molanouri Shamsi M, Woo W, Koyanagi A, Won Lee S, Keon Yon D, Shin JI, Smith L (2023) Effects of physical rehabilitation interventions in COVID-19 patients following discharge from hospital: a systematic review. J Integr Med 21(2):149–158</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joim.2023.01.003</ArticleId><ArticleId IdType="pubmed">36717302</ArticleId><ArticleId IdType="pmc">9851951</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmati M, Shamsi MM, Khoramipour K, Malakoutinia F et al (2022) Baseline physical activity is associated with reduced mortality and disease outcomes in COVID-19: a systematic review and meta-analysis. Rev Med Virol 32(5):e2349</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2349</ArticleId><ArticleId IdType="pubmed">35416354</ArticleId><ArticleId IdType="pmc">9111124</ArticleId></ArticleIdList></Reference><Reference><Citation>Garritson J, Krynski L, Haverbeck L, Haughian JM, Pullen NA, Hayward R (2020) Physical activity delays accumulation of immunosuppressive myeloid-derived suppressor cells. PLoS ONE 15(6):e0234548</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0234548</ArticleId><ArticleId IdType="pubmed">32542046</ArticleId><ArticleId IdType="pmc">7295224</ArticleId></ArticleIdList></Reference><Reference><Citation>Blank M, Israeli D, Shoenfeld Y (2024) Exercise, autoimmune diseases and T-regulatory cells. J Autoimmun 149:103317</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2024.103317</ArticleId><ArticleId IdType="pubmed">39303372</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Su Y, Liu J, Liu D, Yu C (2024) Inhibition of Th17 cell differentiation by aerobic exercise improves vasodilatation in diabetic mice. Clin Exp Hypertens 46(1):2373467</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10641963.2024.2373467</ArticleId><ArticleId IdType="pubmed">38963020</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>